InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Saik Andrew, 首席财务官. Officer active across 3 companies, notably VYNE Therapeutics Inc.. Aggregated, 19 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €89k. History available since 28 May 2021. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Saik Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
5,696 股Common StockSEC:0001628280-26-045286:0
45,000 股0Common StockSEC:0001628280-26-013531:0
5,134 股@ US$11.8957.9% 占其流量Common StockSEC:0001628280-26-009306:0
5,700 股@ US$7.61100.0% 占其流量Common StockSEC:0001655759-25-000109:0
59,600 股0Common StockSEC:0001655759-25-000091:0
49,092 股0Common StockSEC:0001655759-25-000027:0
61,409 股0Common StockSEC:0001655759-24-000105:0
23,021 股@ US$19.0079.2% 占其流量Common StockSEC:0001104659-23-117093:0
908 股@ US$10.808.6% 占其流量Common StockSEC:0001104659-23-103508:0
908 股@ US$11.741.9% 占其流量Common StockSEC:0001104659-23-074233:0
909 股@ US$14.192.3% 占其流量Common StockSEC:0001104659-23-036043:0
14,700 股0Common StockSEC:0001104659-23-008588:0
718 股@ US$12.371.6% 占其流量Common StockSEC:0001104659-23-000337:0
908 股@ US$13.432.2% 占其流量Common StockSEC:0001104659-22-129883:0
908 股@ US$14.852.7% 占其流量Common StockSEC:0001104659-22-102662:0
3,632 股@ US$12.48100.0% 占其流量Common StockSEC:0001104659-22-073886:0
10,300 股0Common StockSEC:0001104659-22-009563:0
52,156 股0Common StockSEC:0001104659-21-084279:0
3,017 股@ US$3.3575100.0% 占其流量Common StockSEC:0001209191-21-037193:0
19 条申报中的 19 条
About Saik Andrew
Saik Andrew is Chief Financial Officer and has 19 filings in total. In the 19 most recent sampled filings, the buy amount is EUR 0 and the sell amount is EUR 88788, over the period from 2021-06-02 to 2026-06-24. The main filings concern Intercept Pharmaceuticals, INC. and Arvinas, INC., with Attribution and sell transactions.
